E

Energenesis Biomedical Co Ltd
TWSE:6657

Watchlist Manager
Energenesis Biomedical Co Ltd
TWSE:6657
Watchlist
Price: 41.05 TWD -4.53% Market Closed
Market Cap: 3.6B TWD

Intrinsic Value

The intrinsic value of one Energenesis Biomedical Co Ltd stock under the Base Case scenario is 1.13 TWD. Compared to the current market price of 41.05 TWD, Energenesis Biomedical Co Ltd is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
1.13 TWD
Overvaluation 97%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation History
Energenesis Biomedical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Energenesis Biomedical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Energenesis Biomedical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Energenesis Biomedical Co Ltd.

Explain Valuation
Compare Energenesis Biomedical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Energenesis Biomedical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Energenesis Biomedical Co Ltd

Current Assets 942m
Receivables 3.2m
Other Current Assets 938.8m
Non-Current Assets 90m
PP&E 81m
Intangibles 4.2m
Other Non-Current Assets 4.8m
Current Liabilities 27m
Accounts Payable 150k
Accrued Liabilities 18m
Other Current Liabilities 8.9m
Non-Current Liabilities 11m
Long-Term Debt 11m
Efficiency

Free Cash Flow Analysis
Energenesis Biomedical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Energenesis Biomedical Co Ltd

Revenue
7.5m TWD
Cost of Revenue
-1.7m TWD
Gross Profit
5.8m TWD
Operating Expenses
-266.8m TWD
Operating Income
-261m TWD
Other Expenses
17m TWD
Net Income
-244m TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Energenesis Biomedical Co Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
27/100
Profitability
Score

Energenesis Biomedical Co Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Energenesis Biomedical Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
68/100
Solvency
Score

Energenesis Biomedical Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Energenesis Biomedical Co Ltd

There are no price targets for Energenesis Biomedical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Energenesis Biomedical Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Energenesis Biomedical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Energenesis Biomedical Co Ltd stock?

The intrinsic value of one Energenesis Biomedical Co Ltd stock under the Base Case scenario is 1.13 TWD.

Is Energenesis Biomedical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 41.05 TWD, Energenesis Biomedical Co Ltd is Overvalued by 97%.

Back to Top